Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

Biocytogen

Biocytogen is listed as a mid sized business research supplier in the Scientist.com network, with 4 sites in 2 countries and 2 service areas.

View Biocytogen on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 4
Countries 2

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Mid sized business

Anatomic Pathology

  • Immunohistochemistry Services Prepare, stain and label with histological and immunological reagents, then evaluate slide preparation of cells or tissue.

Antibodies

  • Antibody based Assay Development Create specific and sensitive assays for the immunodetection of disease-specific target antigens.
  • Antibody Detection Quantitate, localize and visualize proteins and other antigens.
  • Antibody Humanization Increase an antibody's similarity to a variant produced naturally in humans.
  • Antibody Therapy Efficacy In vivo assessment of monoclonal/bispecific antibody efficacy in a humanized mouse
  • Antibody-Dependent Cell-Mediated Cytotoxicity Request services related to cell-mediated immune defense.
  • Antigen Specific T-cells T cell lines that recognize specific peptide antigens to enable analysis of T cell immunity.
Show all 13 in Antibodies 7 more
  • Custom Antibodies Design and produce polyclonal and monoclonal antibodies.
  • Epitope Mapping Map the antibody-antigen binding region to define protein-protein interaction sites.
  • Hybridoma Sequencing/Antibody Sequencing Determine the sequences of monoclonal antibodies.
  • Immunodetection Use antibodies to identify a protein or antigen.
  • In Vitro Monoclonal Antibody Production Generate monoclonal antibodies in vitro using cultured antibody-secreting hybridoma cell lines.
  • Monoclonal/Polyclonal Antibody Development Develop a monoclonal and/or polyclonal antibody.
  • OmniRat Transgenic Animal Platform Produce humanized antibodies using a transgenic rat platform.

Bioimaging

  • Ab-Targeted Positron Emission Tomography Visualize sites of HIV replication that are difficult to access by tissue biopsies.
  • Bioimaging Visualize biological process non-invasively in real time.
  • Confocal/Optical Microscopy Use optical imaging technique to increase optical resolution and contrast of a micrograph.
  • DEXA Body Composition Scan DEXA (Dual-Energy X-ray Absorptiometry) body composition scans are used in medical imaging to measure body composition (including fat and lean body mass and bone mineral density).
  • Fluorescence-Lifetime Imaging Microscopy (FLIM) Use FLIM to produce an image based on the differences in the excited state decay rate from a fluorescent sample.
  • In Vivo Imaging In-vivo imaging using PET, MRI, CT etc.
Show all 16 in Bioimaging 10 more
  • In Vivo Positron Emission Tomography (PET) Imaging Image tumor progression or conduct biodistribution investigations in experimental animals injected with a radiolabeled molecular probe.
  • In Vivo Whole Tissue and Animal Imaging Visualize, analyze and track light producing reporters in whole animals.
  • In-vivo Fluorescence In-vivo fluorescence enables visualisation and the study of biological processes in live organisms by using fluorescent markers.
  • Luminescence Imaging Monitor biological processes and pathologies using reporter proteins such as firefly and Renilla luciferase.
  • Magnetic Resonance Imaging Use MRI to obtain chemical and physical information about molecules and map the internal structure of an object.
  • Medical Imaging Visualize and analyze internal structures in animal models or patients.
  • Microscopy Use microscopy to analyze surfaces of biological materials and to develop 3D images of biological structures.
  • SPECT-CT and PET-CT Imaging Get images that combine the spatial context of metabolic or biochemical activity with an anatomic image.
  • Thermal and Acoustic Imaging Measure the dielectric and optical properties of biological tissues corresponding to pathological states.
  • Ultrasonography diagnostic imaging technique, or therapeutic application of ultrasound.
Show all 489 services 476 more

Biomarkers

  • Adipogenesis Assay Detect and quantify intracellular triglyceride accumulation in adipocytes.
  • Anatomic Pathology Do macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues.
  • Antimicrobial Effectiveness Testing Measure the efficacy of anti-microbial preservatives added to a product.
  • Antioxidant Assays Use biochemical, cell-based or in vivo assays to measure total antioxidant capacity.
  • Autoantibody Testing Screen for the presence of an autoimmune disorder.
  • Basic Metabolic Profiling Set up assays that monitor drug metabolite formation after administration of drug to an animal model or patient.
Show all 59 in Biomarkers 53 more
  • Biomarker Analytical Validation Assess and optimize the characteristics of a candidate biomarker to ensure reproducibility and consistency.
  • Biomarker Discovery Identify a biomarker associated with disease progression of disease, effectiveness of therapy or diagnosis of disease or condition.
  • Biomarker Services Evaluating normal/abnormal biological conditions and characteristics within the body
  • Cell Migration Assays Measure chemotaxis, haptotaxis, transmigration and wound-healing.
  • Cell Viability Measure changes in cell number, cell division, DNA content or a cell metabolism marker such as ATP levels.
  • Cerebrospinal Fluid Analysis Use CSF to detect or monitor a variety of nervous system diseases or conditions.
  • Chemotaxis Assays Investigate the in vivo or in vitro movement of cells towards or away from a chemotactic agent.
  • Complete Blood Count Set of medical laboratory tests that provide information about the cells in blood.
  • Complete Metabolic Panel Testing Detect electrolyte or glucose imbalance to identify or monitor related disorders.
  • Creatine Kinase (CK) Testing Detect and monitor pathologies associated with muscle inflammation or damage.
  • Customized Primary Cell Isolation Plan and execute the isolation of primary cells from a specific biosample.
  • Cytokine Release Assay Use in vivo or in vitro assays to detect unregulated or excessive release of pro-inflammatory cytokines.
  • Endocrine Assays Use biochemical, cell based or in vivo assays to measure the concentration of hormones.
  • Flow Cytometry Identify fluorescently-labeled cells or physically separate cells from a larger population using biomarkers.
  • Fluorescent In Situ Hybridization Use FISH to identify abnormal chromosome structures and to quantify specific DNA sequences.
  • HCS Assay Development Requesting services related to HCS assay development.
  • Hematology CBC Run automated and manual complete blood cell counts (CBCs) as well as microscopic evaluations of cell types.
  • Hematoxylin & Eosin (H&E) Staining Visualize microscopic structures in cells or tissues.
  • Histamine Release Assay Use in vivo or in vitro assays to measure the release of histamine in response to an allergen stimulation.
  • Histopathology Evaluate slide preparation of cells or tissues for abnormal features.
  • Human Primary Cell Isolation Isolate primary cells from various human tissues.
  • Immunoassays Create antibody-based assays for the identification and quantification of specific antigens.
  • Immunohistochemistry Examine the toxic effects of pre-clinical compounds in small animal and patient histological samples.
  • Immunophenotyping Separate cell types based on their expression of biomarkers or based on their individual and unique expression patterns.
  • Immunostaining Use labeled antibodies to detect proteins or other antigens in cells or tissues.
  • In Vivo Apoptosis Detection Visualize and quantify apoptosis in real time.
  • Insulin Autoantibodies (IAA) Testing Detect the risk or presence of type 1 diabetes in early childhood.
  • Interferon Gamma Release Assay Use in vivo or in vitro assays to measure the cell-mediated immune response to an infectious agent.
  • Islet Cell Autoantibodies (ICA) Testing Detect Type 1 diabetes-related autoantibodies.
  • Large Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
  • Lipid Kinase Assays Use biochemical, cell-based or in vivo assays to measure lipid kinase activity.
  • Lipid Peroxidation Assay Use in vitro or in vivo assays to evaluate the effects of oxidative stress on lipid structure and function.
  • Lipid Profiling Use quantitative analysis of blood lipid components to assess cardiac risk.
  • Lipoprotein Associated Phospholipase A2 Testing Assess vascular inflammation and determine the risk for atherosclerosis or arterial plaque rupturing.
  • Microfluidics-Based Biomarker Isolation and Detection Isolate and detect rare biomarkers in blood samples, such as CTCs, cfDNA, and exosomes.
  • Molecular Profiling Modify genome activity without changing the DNA sequence.
  • Myeloperoxidase Testing Detect inflammatory markers and determine the risk for atherosclerosis or arterial plaque rupturing.
  • Paraffin-based Histology Perform sectioning and histological analysis of wax-embedded samples.
  • Peptide Bioanalysis Analyze the structure of Peptides.
  • Peritoneal Fluid Analysis Determine the cause of fluid accumulation in the peritoneal space.
  • Pharmacodynamic Biomarkers Discovery Identify candidate biomarkers indicative of the therapeutic outcome of a drug-target interaction.
  • Plaque Assays Determine infectious viral titer using plaque-forming units or purify viral stocks.
  • Platelet Function Testing Evaluate complete platelet function in vivo or in vitro.
  • Predictive Biomarkers Discovery Identify candidate biomarkers suggestive of a response to a treatment.
  • Prognostic Biomarkers Discovery Identify candidate biomarkers representative of disease progression without treatment.
  • Propidium Iodide FACS Analysis Use DNA staining and flow cytometry to analyze the cell cycle and detect apoptosis or cell proliferation.
  • Protein Bioanalysis Quantitative measurement of xenobiotics (drugs and their metabolites, and biological molecules in unnatural locations or concentrations) and Proteins in biological systems
  • Single Cell Isolation Isolate single cells for subsequent single-cell analysis.
  • Solid Tumor CDx Design and validate companion diagnostics for solid tumors that help select the most appropriate patients, identify patients at increased risk, or monitor treatment effectiveness.
  • Special Stainings Use a variety of techniques for the selective visualization of specific tissue or cell types.
  • Stem Cell Analysis Assess hematopoietic, neural and mesenchymal cell progenitor proliferation and differentiation.
  • TUNEL Assay Detect in situ DNA fragmentation.
  • Wound Healing Assay Use cell-based assays to investigate cell proliferation, cell migration and wound closure.

Cell Culture and Characterization

  • 2D Cell Culture Grow conventional cell cultures in monolayers.
  • 3D Cell Culture Use a scaffold-based or scaffold-free format to grow three dimensional cell and tissue structures.
  • Adherent Cell Culture Grow monolayers of anchorage-dependent cells.
  • Bacterial Cell Culture Culture and Grow bacterial cells.
  • Cell and Tissue Histology Prepare and stain frozen, fixed and embedded (FFPE) tissue samples.
  • Cell Culture Culture primary or immortalized cell lines.
Show all 34 in Cell Culture and Characterization 28 more
  • Cell Line Authentication Verify the identity and purity of an experimental cell line or industrial culture.
  • Cell Line Characterization Track source history and characterize cell lines to establish identity, purity and stability.
  • Cell Line Construction Create new recombinant cell lines to exact specifications.
  • Cell Lines Purchase culture reagents, cell lines and cellular material of any species. Cell Lines typically refer to legacy immortalised cells, that can be cultured and passaged “indefinitely” Primary Cells are cells that have...
  • Cell Transfection Produce, package and optimize transfection of your siRNA or DNA construct.
  • Chromosomal Characterization Establish karyotype/chromosome profile by cytogenetic analysis of cell preparation.
  • Custom 3D Microtissue Development Convert cell lines into highly functional 3D microtissues using scaffold-free self-assembly.
  • Gene-Edited iPSCs Disease Models Use gene-edited iPSCs to model human diseases.
  • H & E Services For requesting services related to H&E Services
  • Histology Examine by microscopy the anatomy of cells and tissues of clinical patients and animal models.
  • Human Melanoma Cell Lines Obtain highly characterized cell lines derived from patients’ tumors for in vitro and in vivo modelling.
  • Induced Pluripotent Stem (iPS) Cell Reprogramming Generate induced pluripotent stem cells from adult somatic cells.
  • Isogenic Knockout iPSC Lines Mimic loss of function of genes associated with various diseases and disorders.
  • Lipofection Transfection of DNA/RNA using lipofection reagents to create lipoplexes.
  • Microsatellite Instability Analysis Compare allelic profiles and detect genomic instability.
  • Mycobacterium Screening Detect and distinguish between mycobacterium strains and species.
  • Mycoplasma Screening Detect mycoplasma contamination of cells or tissues.
  • Mycoplasma Testing Cell line mycoplasma testing services
  • Organotypic Culture Co-culture different cells to enable in vitro growth of an in vivo tissue or organ equivalent.
  • Recombinant Technology Manipulate genotypes to introduce or modify the expression of specific cell products or physical traits.
  • Resin-based Histology Perform sectioning and histological analysis of epoxy/acrylic/polycarbonate-embedded samples.
  • RNA-Based Transfection Deliver RNA to cells by microinjection, electroporation or lipid-mediated transfection.
  • Signaling Pathways Find proteins, assays and custom reagents for the analysis of cell signaling pathways.
  • Stem Cell Differentiation Acquire specialized cells from differentiated stem cells.
  • Stem Cell Methodologies Study Stem Cell characteristics.
  • Suspension Cell Culture Grow anchorage-independent cells in a suspension.
  • Trichrome Staining Use a variety of techniques for the selective visualization of muscle, collagen fibers, fibrin and erythrocytes.
  • Viral Mediated Gene Delivery Use viral carriers to introduce new genetic material into a cell.

Chemical and Compound Analysis

  • Light Sheet Fluorescence Microscopy Use a planar sheet of light to section transparent tissues and generate a 3D image.
  • Ultrasound Tomography Use the transmission and acquisition of ultrasound waves to create a non-invasive technique for imaging.
  • X-ray Microscopy and Nanotomography (Nano-CT) Create two- and three-dimensional imaging of objects in real time.

Chemistry, Manufacturing and Controls (CMC)

  • Bi-specific Antibodies Create a protein made of fragments of two monoclonal antibodies that bind to different antigens.
  • Chemistry, Manufacturing and Controls (CMC) Request Chemistry, Manufacturing and Controls services

Clinical Consulting

  • Cell Services Consulting Whether you are an experienced drug hunter working in the pharmaceutical industry or an academic researcher looking to submit g...

Developmental and Reproductive Toxicology (DART)

  • Early-Life Stage Toxicity Test Use survival and growth metrics of embryos or larvae to predict effects or find maximum acceptable value of a toxin.
  • Embryo-Fetal Development (EFD) Study (Segment II) Test drug candidate in Segment II toxicology services.
  • Embryo-Fetal Development (EFD) Study (Segment II) - Mouse Conduct a study to determine the effect of compound exposure on the pregnant mouse and the developing fetus.
  • Embryo-Fetal Development (EFD) Study (Segment II) - Rat Conduct a study to determine the effect of compound exposure on the pregnant rat and the developing fetus.
  • Fertility and Embryonic Development Study (Segment I) Test drug candidate in Segment I toxicology services.
  • Fertility and Embryonic Development Study (Segment I) - Mouse Conduct a study to determine the effect of your compound on the estrous cycle, spermatogenesis/male reproductive organs, fertility of parents, and development of the embryo in mice.
Show all 12 in Developmental and Reproductive Toxicology (DART) 6 more
  • Fertility and Embryonic Development Study (Segment I) - Rat Conduct a study to determine the effect of your compound on the estrous cycle, spermatogenesis/male reproductive organs, fertility of parents, and development of the embryo in rats.
  • Juvenile Toxicity Study - Dog / Canine Conduct a study to determine the differences in toxicity between immature and mature systems in dogs.
  • Juvenile Toxicity Study - Rat Conduct a study to determine the differences in toxicity between immature and mature systems in rats.
  • Pre/Post-Natal Development (PPND) Study (Segment III) - Mouse Conduct a study to quantify the effect of your compound on fetal development, parturition, and post-natal development in mice.
  • Pre/Post-Natal Development (PPND) Study (Segment III) - Rat Conduct a study to quantify the effect of your compound on fetal development, parturition, and post-natal development in rats.
  • Reproductive Toxicology Study adverse sexual function and fertility and examine teratogenicity of compounds.

Discovery Chemistry

  • Custom Libraries Find or synthesize mg to kg amounts of target-specific and target-agnostic compounds for HTS and biological profiling.

Disease Models

  • Acute Kidney Failure Models Measure therapeutic endpoints in animal models of acute kidney failure.
  • Acute Liver Failure Models Measure therapeutic endpoints in animal models of acute liver failure.
  • Acute Lung Injury Models Measure therapeutic endpoints in animal models of acute lung injury.
  • Arthritis Models Measure therapeutic endpoints in animal models of arthritis.
  • Atopic Dermatitis Models Measure therapeutic endpoints in animal models of atopic dermatitis.
  • Autoimmune Models Measure therapeutic endpoints in animal models with autoimmune disorders.
Show all 78 in Disease Models 72 more
  • Behavioral Testing Models Investigate sensory-motor and emotional functions, social behavior and day-night activity.
  • Blood Models Test for therapeutic efficacy of drug candidates in blood disorder models.
  • Cardiovascular Metabolics Models Measure therapeutic endpoints in animal models of cardiovascular disorders.
  • Cardiovascular Models Test the therapeutic efficacy of drug candidates in cardiovacular disease models.
  • Chronic Kidney Disease Models Measure therapeutic endpoints in animal models of chronic kidney disease.
  • Cognition Models Measure therapeutic endpoints in animal models of cognition.
  • Comparative Pharmacology Compare drug responses across species for improved reliability in translational studies.
  • Cyp2f2 Knockout Mouse Study Cyp2f2-mediated lung metabolism.
  • Demyelination Models Measure therapeutic endpoints in animal models with demyelination pathology.
  • Dermatology Model Consulting Whether you are an experienced drug hunter working in the pharmaceutical industry or an academic researcher looking to submit g...
  • Dermatology Models Measure therapeutic endpoints in animal models of dermatological disorders.
  • Diabetic Retinopathy Models Assess therapeutic efficacy of drug candidates in diabetic retinopathy models of disease.
  • Drug-Induced Liver Injury (DILI) Toxicity Assays Use biochemical, cell-based or in vivo assays to measure toxicity from drug-induced liver injury.
  • Endometriosis Models Measure therapeutic endpoints in animal models of endometriosis.
  • Experimental Epilepsy Models Use chronic or induced animal models of epilepsy to test your drug candidate for therapeutic efficacy.
  • General Pain Models Measure therapeutic endpoints in animal models of general pain.
  • Hair Growth Models Measure dermal histology, skin thickness, % anagen induction, hair proliferation and other hair growth markers.
  • Hematopoiesis Models Measure therapeutic endpoints in animal models of hematopoiesis.
  • Hepatitis B Virus Models Measure therapeutic endpoints in animal models of Hepatitis B virus infection.
  • Hepatitis C Virus Models Measure therapeutic endpoints in animal models of Hepatitis C virus infection.
  • Huntington's Disease Models Measure therapeutic endpoints in animal models of Huntington's disease.
  • In Vivo Physiologic Monitoring Monitor and collect data from conscious, freely moving laboratory animals.
  • In Vivo Technologies Models Carry out EEGs, cognition assessment, microdialysis, electrophysiology, MRI, ultrasound and tomographic analysis.
  • Infectious Disease Model Consulting Whether you are an experienced drug hunter working in the pharmaceutical industry or an academic researcher looking to submit g...
  • Infectious Disease Models Test therapeutic efficacy of drug candidate in infectious disease model.
  • Inflammation Model Consulting Measure therapeutic endpoints in animal models for inflammation.
  • Inflammation Models Measure therapeutic endpoints in animal models for inflammation.
  • Inflammatory Bowel Disease Models Measure IBD symptom severity, cytokine levels and body weight, and evaluate IHC and Ariol images.
  • Inflammatory Pain Models Measure therapeutic endpoints in animal models of inflammatory pain.
  • Irritant Models Measure therapeutic endpoints in animal models of skin irritation.
  • Ischemia Models Measure therapeutic endpoints in animal models of ischemia.
  • Kidney Transplant Models Measure therapeutic endpoints in kidney transplant models.
  • Liver Disease Animal Models Measure therapeutic endpoints in animal models with liver disease.
  • Liver Fibrosis Models Measure liver fibrosis using therapeutic endpoints such as collagen assessment, TUNEL staining and inflammatory markers.
  • LPS Acute Response Models Measure therapeutic endpoints in acute models of inflammation.
  • LPS Lung Inflammation Models Measure therapeutic endpoints in animal models of inflammation.
  • Macular Degeneration Models Use a single animal species to create one or more models for eye disease.
  • Microsurgery in Rodents Outsource microsurgeries projects required for testing new therapies on a rodent model.
  • Morris Water Maze Investigate spatial learning and memory in rodents.
  • Myelination Models Measure therapeutic endpoints in animal models with induced myelination, remyelination or developmental myelination.
  • Neuroscience Models Test therapeutic efficacy of drug candidate in neurological disease model.
  • Ob/ob Mouse Use a single animal species to create one or more disease models obesity and angiogenesis.
  • Obese Mice Use a single animal species to create one or more disease models for diet-induced obesity and type II diabetes.
  • Object Recognition Measure spatial navigation, working memory and cognitive function in animal models.
  • Ocular Inflammation Models Measure ocular inflammation in models of eye disorders such as uveitis and keratitis.
  • Ophthalmic Models Test drug candidates in glaucoma, macular degeneration, keratitis, uveitis and CMV retinitis models.
  • Ophthalmology Consulting Whether you are an experienced drug hunter working in the pharmaceutical industry or an academic researcher looking to submit g...
  • Optogenetics (rodent behavioral testing) Use light to selectively control the molecular events in cells of living organisms.
  • Osteoarthritis Models Measure therapeutic endpoints in animal models of osteoarthritis.
  • Osteoporosis Models Measure therapeutic endpoints in animal models of osteoporosis.
  • OVA Lung Inflammation Models Measure therapeutic endpoints in animal models of inflammation.
  • Pain Endpoints Models Measure therapeutic endpoints in animal models of pain.
  • Pain Model Consulting Expert advice to better evaluate and understand pain thresholds and phenomena within living organisms. Can be used to evaluate pain associated with specific diseases or injuries affecting the sensory and nervous systems.
  • Pain Models Test therapeutic efficacy of drug candidate in pain model.
  • Parkinson's Disease Models Measure therapeutic endpoints in animal models of Parkinson's disease.
  • Pulmonary Fibrosis Models Measure therapeutic endpoints in animal models of pulmonary fibrosis.
  • Receptor Binding Models Measure the binding and distribution of drugs and biologics in animal tissues.
  • Respiratory Model Consulting Whether you are an experienced drug hunter working in the pharmaceutical industry or an academic researcher looking to submit g...
  • Respiratory Models Test therapeutic efficacy of drug candidate in respiratory disease model.
  • Schizophrenia Models Measure therapeutic endpoints in animal models of schizophrenia.
  • Sclerosis ALS Models Measure therapeutic endpoints in animal models of sclerosis.
  • Skin Graft Models Measure therapeutic endpoints in animal models of skin grafts.
  • Spinal Cord Injury Models Measure therapeutic endpoints in models of spinal cord injury.
  • Streptozotocin Rats Use a single animal species to create one or more disease models for Type 1 diabetes.
  • Stroke Models Measure therapeutic endpoints in animal models of stroke.
  • Systemic Lupus Erythematosus Models Measure therapeutic endpoints in animal models of immune disorders such as SLE and lupus.
  • Thrombosis Models Measure therapeutic endpoints in animal models of thrombosis.
  • Tissue Rejection Models Measure therapeutic endpoints in animal models of tissue rejection.
  • Viral Infection Models Measure therapeutic endpoints in animal models of viral infection.
  • Visceral Pain Models Measure therapeutic endpoints in animal models of visceral pain.
  • Wound Healing Models Measure therapeutic endpoints in animal models of wound healing.
  • Xenografts Evaluate drug candidate in tissue graft or organ transplant model.

DNA & RNA

  • CRISPR Using advanced CRISPR technology, add or delete base pairs at a specifically targeted DNA loci.
  • Genome Editing Use CRISPR, ZFN, TALEN or AAV gene targeting for targeted gene mutations and creation of transgenics.

Drug Development

  • Safety Pharmacology Consulting Consulting services that help with the detection of potential undesirable pharmacodynamic effects of chemical entities on physiological functions.

Drug Metabolism and Pharmacokinetics (DMPK)

  • Biomarkers DMPK Biomarker DMPK and gene analysis services are critical tools in evaluating patients and discovery of new therapeutics.

General in vivo Toxicology

  • Carcinogenicity Study - Mouse Conduct a repeat dose, chronic carcinogenicity study in mice to determine the tendency of your compound to produce tumors.
  • Carcinogenicity Study - Rat Conduct a repeat dose, chronic carcinogenicity study in rats to determine the tendency of your compound to produce tumors.
  • Dose Range Finding Study - Dog /Canine Conduct a study to determine the dose range of your compound in dogs/canines.
  • Dose Range Finding Study - Mouse Conduct a study to determine the dose range of your compound in mice.
  • Dose Range Finding Study - Rat Conduct a study to determine the dose range of your compound in rats.
  • Effective Dose (ED), 50% Toxicity Test Quantify the diluted toxin needed to induce sub-lethal effects upon constant exposure in half of test organisms.
Show all 19 in General in vivo Toxicology 13 more
  • General Toxicology Use in vivo models to assess acute and sub-acute toxicity as well as chronic and sub-chronic toxicity.
  • IV Toxicology Test the toxicological effect of IV delivery of drug candidate.
  • Mammalian Toxicology Use toxicity testing models to carry out required FDA or REACH safety testing.
  • Nonclinical Study Management Provide nonclinical study management services to pharmaceutical and biotech companies. The services can be customized to meet the clients needs.
  • Nonclinical Study Monitoring Provide nonclinical study monitors throughout the US and Canada to monitor in vivo and in vitro studies are CROs
  • Repeat Dose Toxicity Study - Dog / Canine Conduct a repeat dose study in dogs to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Toxicity Study - Mouse Conduct a repeat dose study in mice to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Toxicity Study - Rat Conduct a repeat dose study in rats to determine the toxicity and toxicokinetic behavior of your compound.
  • Short-Term Toxicity Tests Acquire preliminary data about the concentrations, exposure duration and effects of a toxin on organisms.
  • Single Dose Acute Toxicity Study - Dog / Canine Conduct a single dose study in Dogs and Canines to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Toxicity Study - Mouse Conduct a single dose study in Mice and Murines to determine the toxicokinetic behavior of your compound.
  • Single Maximum Tolerated Dose (MTD) Mouse Study Use mouse models to determine the MTD of a drug candidate by a single administration in a 7 day period.
  • Single Maximum Tolerated Dose (MTD) Rat Study Use rat models to determine the MTD of a drug candidate by a single administration in a 7 day period.

In Vitro ADME

  • Blood Brain Barrier Measure movement of drugs from circulating blood to brain extracellular fluid.
  • Cell Fractionation Isolate organelles and subcellular components.
  • Cell Permeability and Absorbance Models Cell Permeability and Absorbance Model assay.
  • Compound Distribution Determine the metabolic fate of a drug candidate in tissue and organs of diseased and normal animal models.
  • Conjugate Detection Measure the conjugation of endogenous small molecules to drug candidates after in vivo administration.
  • Drug Distribution Studies Determine the metabolic fate of compounds within tissues, organs and plasma.
Show all 14 in In Vitro ADME 8 more
  • Drug Drug Interactions Determine whether a substance affects the activity of a drug when both are administered together.
  • In Vitro ADME in Vitro ADME services
  • In Vitro Biologic-Small Molecule Drug-Drug Interaction Studies Patented approach to evaluate the potential of large &/or small molecule drugs to cause DDI directly or through cytokine effect.
  • Intestinal Permeability Use Caco 2 and MCDK cells to assess mono-directional drug transport by passive diffusion in culture.
  • Metabolic Stability Measure metabolic vulnerability to drug metabolizing enzymes using cell-free, cell-based and in vivo assays.
  • Metabolite Quantification Quantify drug metabolites formed after drug administration to an animal model or patient.
  • Plasma Stability Assay Determine degradation rate of drug candidates in plasma.
  • Red Blood Cell (RBC) Partitioning (Blood/Plasma Ratio) Measure the distribution of a compound between red blood cells and plasma.

In Vitro Assays

  • Annexin V Apoptosis Assay Detect and quantify apoptotic cells based on loss of membrane asymmetry.
  • Antivirals Measure anti-viral activity in biochemical and cell assays.
  • Apoptosis Assays Detect apoptotic events that lead to programmed cell death.
  • Apoptotic Cell Staining Detect apoptotic cells in culture.
  • Assay Development Construct or create new assays or modify existing ones.
  • Assay Kits Can't find what you're looking for? Click here to submit a request to multiple vendors for assay kits.
Show all 36 in In Vitro Assays 30 more
  • BrdU S-Phase Analysis Assess cell division or apoptosis by measuring thymidine-analog label incorporation during DNA replication.
  • Caspase Assay Detect early to mid stage apoptosis or differentiate apoptosis from necrosis.
  • Cell Based Assays Apply compounds to cells and test for cellular phenotypes and effects on gene expression
  • Cell Based Assays Consulting Expert advice to evaluate the functions of specific chemicals based on their constructions and systems.
  • Cell Cycle Assays Measure cell cycle markers and the molecular events that control cell cycle progression.
  • Cell Proliferation Measure cell number, cell viability and cell division.
  • Cell-based Screening Assays Apply compounds to cells and test for cellular phenotypes and effects on gene expression
  • Cytometric Bead Array (CBA) FACS Analysis Use flow cytometry and antibody-coated beads to simultaneously detect multiple target proteins.
  • ELISpot Assay and Testing Detect low levels of antigens.
  • Endpoint Dilution Assay (TCID50) Assay Determine the viral titer to induce cell death in half the cell population of an inoculated tissue culture.
  • Fully Automated Assays Develop and perform assays that require no manual steps
  • Glucose Release Assay Determine free glucose levels in biological samples.
  • Human Immuno-deficiency Virus Infection CDx Design and validate companion diagnostics for HIV infection that help select the most appropriate patients, identify patients at increased risk, or monitor treatment effectiveness.
  • Hydroxyproline Assays Use biochemical, cell based or in vivo assays to quantify hydroxyproline or collagen in a sample.
  • In Vitro Assay Development Develop innovative assay and screening methods outside a living organism to enable a wide range of pre-clinical activities.
  • In Vitro Efficacy Test Use in vitro models to test the efficacy of your products.
  • In Vitro Human Cell Assays Request in vitro human cells for assays
  • Inflammation Assays Identify and validate pro- and anti-inflammatory molecules, recruitment inhibitors and chemotaxis modulators.
  • Lipid Detection Use in vitro methods to identify lipid droplets and any associated proteins.
  • Luciferase Reporter Assay Evaluate promoter activity by measuring light output from the luciferase enzyme.
  • Microbiology Study microbes and their role in human health.
  • Organoid Screening Assay Evaluate the effects of various substances, such as drugs or genetic modifications, on organoids.
  • Pathogen Assays Detect and distinguish viral, bacteria and fungal strains and species.
  • Pathway Mapping Define mechanisms of action by analyzing protein pathways affected by drug treatment.
  • Phenotype Assays Measure effects of drug candidate on the morphology or function of cells and whole animals.
  • PrimeFlow™ RNA Assay Reveal the unique kinetics of mRNA and protein in the same cell and identify expression differences as they change over time in response to stimulus.
  • Reporter Virus Particles (RVPs) - Dengue Neutralization Assay Use Dengue Reporter Virus Particles to measure neutralizing antibodies against each of the four Dengue serotypes.
  • Serine Protease Assay Detect apoptosis by measuring protease activity.
  • Viral Clearance Assays Measure the capacity to remove or inactivate infectious agents during the manufacturing process.
  • Virus Detection Assays Use ultra-sensitve methods to reliably detect low level viruses.

In Vitro Pharmacology

  • Anaplastic lymphoma kinase (ALK) Assays Use biochemical, cell based or in vivo assays to measure ALK enzyme activity.
  • ATP Competitive Study Determine whether or not a compound is competitive with ATP.
  • Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Assays Use biochemical, cell based or in vivo assays to measure CTLA-4 receptor activity.
  • Drug Target Assays Gain insight into the selectivity and mode-of-action of a compound's pharmacological targets.
  • Drug Target Assays Consulting Whether you are an experienced drug hunter working in the pharmaceutical industry or an academic researcher looking to submit g...
  • Extracellular signal Regulated Kinase Assays Use biochemical, cell based or in vivo assays to measure ERK enzyme activity.
Show all 44 in In Vitro Pharmacology 38 more
  • Fibroblast Growth Factor Receptor (FGFR) Assays Use biochemical, cell based or in vivo assays to measure FGF receptor activity.
  • G-Protein Coupled Receptor (GPCR) Assays Detect ligand binding, receptor dimerization and downstream signal transduction events.
  • Glucose Transporter Assays Use biochemical, cell-based or in vitro assays to measure glucose transporter activity.
  • HuGEMM - Immuno-Oncology Model Evaluate human-specific therapeutics for checkpoint inhibitors, including anti-human PD-1, anti-human PDL-1, and anti-human CTLA-4 antibodies.
  • Human BCL Assays Use biochemical, cell-based or in vivo assays to measure BCL activity.
  • Human Epidermal growth factor Receptor (HER) Assays Use biochemical, cell based or in vivo assays to measure HER receptor activity.
  • Immuno-oncology Assays Use biochemical, cell based or in vivo assays to measure the activity of immuno-therapy targets.
  • Immuno-oncology Targets Develop drugs that take advantage of the immune system to target cancer cells.
  • In Vitro Disease Models Screen pre-clinical candidates without the use of live animals.
  • In Vitro Enzyme Activity Assay Development Develop new in vitro enzyme activity assays or modify existing ones.
  • In Vitro Hemolysis Assay Evaluate the toxicity of a drug, metabolite or excipient by hemolytic release of hemoglobin in the plasma.
  • In Vitro Neural Models Use cultured neurons, neuronal progenitor cells and stem cell differentiation to create cellular models of neurological disease.
  • In Vitro Oncology Models Use cell-based and biochemical models of cancer.
  • Kinase Assays Measure activity of over 500 kinases in biochemical or cell-based assays.
  • Liposome Immunoassay Use immuno-liposomes for improved signal intensity and detection sensitivity compared to enzyme and fluorescent immunoassays.
  • Mammalian Target of Rapamycin Complex Assays Use biochemical, cell based or in vivo assays to measure mTORC enzyme activity.
  • Methyltransferase Assays Use biochemical, cell-based or in vitro assays to measure methyltransferase activity.
  • Nuclear Receptor Assays Measure nuclear receptor activity in biochemical and cell assays.
  • Nucleoside Transporter Assays Use biochemical, cell-based or in vivo assays to measure nucleoside transporter activity.
  • PARP Assays Use biochemical, cell-based or in vivo assays to measure PARP activity.
  • Peptide Transporter Assays Use biochemical, cell-based or in vivo assays to measure peptide transporter activity.
  • Phosphatidylinositol 3-Kinase (PI3K) Assays Use biochemical, cell based or in vivo assays to measure PI3K enzyme activity.
  • Potassium Channel Assays Use biochemical, cell-based or in vivo assays to measure potassium channel activity.
  • Programmed Cell Death-1 (PD-1) Assays Use biochemical, cell based or in vivo assays to measure PD-1 receptor activity.
  • Programmed Death-Ligand 2 (PD-L2) Assays Use biochemical, cell based or in vivo assays to monitor competitive or non-competitive binding of PD-L2 ligand.
  • Protein Kinase B (Akt) Assays Use biochemical, cell based or in vivo assays to measure Akt enzyme activity.
  • Protein Targets Protein Targets are of pharmaceutical interest for drug discovery purposes.
  • Protein/Enzyme Targets For requesting Protein/Enzyme Targets
  • RAS Assays Use biochemical, cell based or in vivo assays to measure RAS enzyme activity.
  • Sodium Channel Assays Use biochemical, cell-based or in vivo assays to measure sodium channel activity.
  • Substrate Competitive Study Determine whether or not a compound is competitive with a substrate.
  • Target Characterization Characterize potential drug targets during the drug discovery process.
  • Target Identification Identify the target(s) of a biologically active substance.
  • Target Validation Demonstrate that modification of target activity has potential therapeutic benefits.
  • Time Dependent Study Determine whether or not a compound binds to an enzyme in a time-dependent manner.
  • Ubiquitin Ligase Assays Measure ligase enzyme activity in the presence of cofactors or chemical modifiers.
  • Vascular Endothelial Growth Factor (VEGF) Assays Use biochemical, cell based or in vivo assays to monitor competitive or non-competitive binding of VEGF ligand.
  • Vascular Endothelial Growth Factor Receptor (VEGFR) Assays Use biochemical, cell based or in vivo assays to measure VEGF receptor activity.

In Vitro Toxicology

  • ADCC and CDC Assay Services Measure toxicity of antibodies.
  • Cardiomyocyte Toxicity Assess cytotoxic effects of pre-clinical compounds on cardiomyocytes.
  • Cardiotoxicity Evaluate the effect of a compound on heart electrophysiology and muscle function.
  • Cardiovascular Toxicology Measure the toxic effects of pre-clinical compounds.
  • Cytotoxicity Test for effects on cell viability and proliferation
  • Cytotoxicity Testing Determine whether a cosmetic product or ingredient is toxic to in vitro cell cultures.
Show all 15 in In Vitro Toxicology 9 more
  • Endothelial Cell Toxicity Assess the cytotoxic effects of pre-clinical compounds on the vascular system.
  • Epidermal Cell Toxicity Measure toxicity by quantifying the number of live/dead cells, cell membrane integrity and glutathione (GSH) levels.
  • Genotoxicity Evaluate potential of a compound to cause mutations and chromosomal aberations
  • Hematopoietic Cell Toxicity Examine cytotoxic effects of pre-clinical compounds or biologics on adult stem cells.
  • Hepatocyte Toxicity Assess the cytotoxic effects of pre-clinical compounds on hepatocytes purified from patients and animal models.
  • Perfused Heart Examine cardiac contractile strength (inotropic effects), heart rate (chronotropic effects) and vascular effects.
  • Short Time Exposure (STE) Test Use in vitro eye irritation tests to assess cytotoxicity in SIRC cells (rabbit corneal cell line).
  • Toxicology- in vitro Toxicity testing and model development in vitro on developmental and adult neurotoxicity
  • Tubule Epithelial Cell Toxicity Assess the cytotoxic effects of pre-clinical compounds on the kidney.

In Vivo ADME

  • Absorption studies Study the factors determning how efficiently a compound may enter the bloodstream.
  • Mass Balance Study - Rat Conduct a study to investigate the plasma pharmacokinetics and excretion of your compound as well as total radioactivity in rats.
  • Ocular Distribution Study - Rat Conduct a study to determine the distribution of your compound in ocular tissues of the rat.
  • Tissue Distribution Study the tissues in which a compound or its metabolites, accumulate.

In Vivo Pharmacokinetics

  • In Vivo Immunogenicity Study An in vivo immunogenicity study evaluates a substance's ability to trigger an immune response within a living organism.
  • In Vivo Pharmacokinetics Run pharmacokinetic studies in animals that measure a drug's absorption, distribution, metabolism and excretion (ADME).
  • In Vivo PK Consulting Expert advice on pharmacokinetics and how specific drugs affect the body to determine function, effectiveness, dosage size, etc…
  • Integrated In Vivo Services Package Process an entire In Vivo Project including: Dose Formulation, PK Screening, ADME-Profiling, Toxicology, Safety Pharmacology, DART, IND Filing from our bundle of suppliers.
  • Mass Balance Elucidate excretory pathways and organ distribution of a parent drug and metabolites
  • Maximum Tolerated Dose (MTD) Studies Determine Maximum Tolerated Dose (MTD) of a drug candidate in either a single or repetitive dosing study in a rodent (typically mouse or rat).
Show all 18 in In Vivo Pharmacokinetics 12 more
  • Mouse Efficacy Monotherapy Use mouse models to determine the anti-cancer efficacy of a drug candidate compared to a positive control.
  • Ocular Pharmacokinetic (PK) Screening - Dog / Canine Conduct a pharmacokinetic screening study in dogs/canines that measures the absorption, distribution, metabolism and excretion of your compound following ocular administration.
  • Ocular Pharmacokinetic (PK) Screening - Rat Conduct a pharmacokinetic screening study in rats that measures the absorption, distribution, metabolism and excretion of your compound following ocular administration.
  • Pharmacokinetic (PK) Screening Measure the absorption, distribution, metabolism and excretion of a compound.
  • Pharmacokinetic (PK) Screening - Dog / Canine Run pharmacokinetic studies in dogs that measure a drug’s absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Mouse Run pharmacokinetic studies in mice that measure a drug's absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Other Species Run pharmacokinetic studies in large animals that measure a drug's absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Rat Run pharmacokinetic studies in rats that measure a drug's absorption, distribution, metabolism and excretion.
  • Rat Efficacy Combination Use rat models to determine the anti-cancer efficacy and potential synergy of a drug candidate with a standard drug treatment.
  • Rat Efficacy Monotherapy Use rat models to determine the anti-cancer efficacy of a drug candidate compared to a positive control.
  • Repetitive Maximum Tolerated Dose (MTD) Mouse Study Use mouse models to determine the MTD of a drug candidate by repetitive administrations for 7 days.
  • Repetitive Maximum Tolerated Dose (MTD) Rat Study Use rat models to determine the MTD of a drug candidate by repetitive administrations for 7 days.

Model Development

  • Animal Model Development Create new systems for profiling pre-clinical therapeutics, devices, and surgical techniques.
  • Custom Model Development Develop a custom disease model.
  • Disease Model Database For sourcing disease models.
  • Knockin Mice Make targeted insertion of a gene of interest into a specific gene locus to create transgenic mice.
  • Knockout Mice Create transgenic mice that are genetically engineered to inactivate a gene or set of genes.
  • Lewis Rat Use a single animal species to create one or more disease models for metastatic cancer, hematopoiesis and anemia.
Show all 18 in Model Development 12 more
  • NMRI Mouse Use a single animal species to create one or more disease models for cachexia and hemophilia.
  • PBMC Humanized Mice Study and evaluate compounds for infectious diseases and graft rejection.
  • PiggyBac Transgenic Mouse Service Obtain single-copy transgenic embryos with consistent expression of any desired transgene.
  • Pre-clinical Animal Surgery Conduct surgey in animals used as pre-clinical models.
  • Pseudopregnant CD1 Mouse Use a single animal species to create gene-modified mouse models.
  • Pulmonary Hypertension Animal Model Study the pathology of pulmonary arterial hypertension (PAH) and investigate potential therapies.
  • SCID Mouse Use a single animal species to create one or more disease models for spontaneous and metastatic cancer and cachexia.
  • Sprague Dawley Rat Use a single animal species to create one or more disease models for cachexia.
  • STAM™ model (NASH-HCC model mouse) At SMC, we have created the world’s first NASH to liver cancer model called STAM™. It shows the same progression from fatty liver (steatosis), to inflammation (NASH), to fibrosis, to Liver Cancer (hepatocellular...
  • Standard Models Create new animal disease models or modify existing models to study specific diseases, side-effects or symptoms.
  • Surgical Models Create new animal models using techniques such as vascular catherization, soft tissue procedures or device implants.
  • Transgenic Models Create animal models engineered for use in a specific therapeutic area.

Neurotoxicology

  • Single Dose Acute Neurotoxicity Study - Rat Conduct a single dose study in rats to determine the neurotoxicty of your compound.

Oncology Models

  • Angiogenesis Models Measure therapeutic endpoints in animal models of angiogenesis.
  • Animal Hypoxia Models Measure therapeutic endpoints in hypoxic animal models.
  • Athymic Mouse Use a single animal species to create one or more disease models for cachexia and spontaneous cancer.
  • CAR-T Efficacy In Vivo assessment of CAR-T and CAR-NK efficacy in a humanized mouse
  • Digestive System PDX Patient derived xenografts relating to organs and components of the digestive system. This includes, but is not limited to the Stomach, Intestines, Liver, Colon, Colorectal samples and Gastric samples.
  • Endocrine System PDX Patient derived xenografts related to the endocrine system. PDX related to glands controlling hormone regulation such as the Pituitary glands, Thyroid Glands, Adrenals, and Pancreas.
Show all 24 in Oncology Models 18 more
  • Endocrine System Xenograft Xenografts derived from organs and glands of the Endocrine system. This include samples from the Pituitary Gland, Thyroid, and Adrenals.
  • Experimental Metastatic Models Measure therapeutic endpoints in animal models of experimental metastatic cancer.
  • Hematological Cancer PDX Design and validate companion diagnostics for hematological cancer that help select the most appropriate patients, identify patients at increased risk, or monitor treatment effectiveness.
  • Immuno-PDX Utilize the patient-derived xenograft for drug response profiling and biomarker discovery of immuno-oncology drug candidates.
  • Leukemia PDX Measure therapeutic endpoints in patient-derived xenografts of leukemia.
  • Murine Adenocarcinoma 16 (MAC16) Murine Test for therapeutic efficacy of drug candidates in muscle wasting models.
  • NCG Model Study tumor biology and immuno-oncology in the CRISPR/Cas9-generated immunodeficient mouse model.
  • Nervous System PDX Patient derived xenografts relating to the components of the Nervous System. This includes PDX from the Brain, Spinal Cord, and Nerves.
  • Nervous System Xenografts Xenografts relating to the Nervous system. This includes samples from the Head, Neck, Brain, and Nerves.
  • Oncology Derived PDX Patient derived xenografts derived from various oncological samples. This includes, but is not limited to, samples from Lymphoma, Melanoma, and Leukemia.
  • Oncology Models Use model organisms to test the therapeutic efficacy of cancer drug candidates.
  • Oncology Xenografts Xenografts derived from oncological samples.
  • Ovarian Cancer Mouse Measure therapeutic endpoints in animal models of ovarian cancer.
  • Reproductive System PDX Patient derived xenografts relating to reproductive systems. This includes PDX from reproductive organs such as the Ovaries, Cervix, Breasts, Testes, Prostate, and Scrotum.
  • Reproductive System Xenografts Xenografts relating and derived from the reproductive systems. This includes samples from the ovaries, cervix, vulva, uterus, testes, scrotum, and prostate.
  • Urinary System PDX Patient Derived Xenografts relating to organs that comprise the Urinary system. This includes, but is not limited to, samples from the Kidneys, Liver, and Bladder.
  • Urinary System Xenografts Xenografts derived from organs of the Urinary system. This includes, but is not limited to, xenografts from the Bladder, Kidney, and Urethra.
  • Xenograft Models Measure therapeutic endpoints in cancer models using tumor cells transplanted from a donor of a different species.

Other Specialty Toxicology

  • Biosafety Testing In Vitro Test biologics, raw materials, lot release and viral safety
  • Microbial Testing Test samples for microorganisms, identify species, do bioburden analysis and measure endotoxin levels (LAL).
  • Microdilution Testing Simultaneously quantify the susceptibility of a microbial species or strain to multiple anti-microbial agents.
  • Residual DNA Analysis Measure contaminants found in therapeutics like biologicals and biosimilars that are produced in cells.
  • Tumorigenicity Testing Test tumor-forming properties of cell products.

Pharmacology

  • In Vivo Services Suppliers that house animals of any species.

Protein Sciences

  • Cytokines Find recombinant cytokines or cytokine assays.
  • ELISA Detect the presence of antigens recognized by antibodies or find antibodies that recognize an antigen.

REACH Services

  • Ex Vivo REACH Assays Perform testing on cells or tissues cultured directly from a test organism
  • Hazard, Exposure and Risk Assessment Evaluate the known hazard of a test compound in conjunction with the expected quantity and frequency of exposure.
  • In Vitro REACH Services Perform skin or eye irriation tests, sensitivily and geneotoxicity tests
  • In Vivo REACH Services Performing testing when in vitro studies cannot be used to predict biological responses
  • OECD 402: Acute Dermal Toxicity This method provides information on health hazard likely to arise from short-term exposure to a test chemical by dermal route.
  • OECD 403: Acute Inhalation Toxicity This method provides information on health hazard likely to arise from short-term exposure to a test article (gas, vapour or aerosol/particulate test article) by inhalation.
Show all 11 in REACH Services 5 more
  • OECD 406: Skin Sensitisation This method provides information on health hazard likely to arise from exposure to test substance via intradermical injection and/or epidermical application.
  • OECD 426: Developmental Neurotoxicity Study A developmental neurotoxicity study will provide information on the effects of repeated exposure to a substance during in utero and early postnatal development.
  • OECD 451: Carcinogenicity Studies The objective of a long-term carcinogenicity study is to observe test animals for a major portion of their life span for the development of neoplastic lesions during or after exposure to various doses of a test...
  • OECD 452: Chronic Toxicity Studies Evaluate the direct and indirect impact of prolonged and repeated toxin exposure to test organisms.
  • OECD 489: In Vivo Mammalian Alkaline Comet Assay Measure the mitogenic and genotoxic potential of test compounds.

Safety Pharmacology

  • CNS Behavioral Measure safety toxicology effects of CNS and behavioral drugs.
  • Conditioned Place Preference or Aversion Study - Mouse Conduct a study to establish the aversion or conditioned place preference and determine the motivational effect of your compound in mice.
  • Conditioned Place Preference or Aversion Study - Rat Conduct a study to establish the aversion or conditioned place preference and determine the motivational effect of your compound in rats.
  • Cytokine Release Syndrome In Vivo assessment of cytokine release syndrome liability in a humanized mouse
  • Dependence Potential Study - Rat Conduct a study to determine the dependence potential of your compound in rats.
  • Drug Discrimination Study - Rat Conduct a study to investigate the length of psychoactive effects of your compound in rats and conduct dose range finding for further studies.
Show all 17 in Safety Pharmacology 11 more
  • Immunotoxicity Measure effects of drugs on immune function, allergic hypersensitization and autoimmune toxicity.
  • Implanted Telemetry Study - Rat Conduct a study that allows the continuous collection of cardiovascular data following dosing of your compound in rats.
  • Locomotor Activity Assessment Study - Rat Conduct a study to determine the psychostimulant or sedative activity or your compound in rats.
  • Neurotoxicity Study Study of the adverse effects of a substance on the brain or peripheral nervous system.
  • Off Target Effects Assess toxicities by body weight, clinical chemistry, hematology, urinalysis and terminal necropsy and pathology.
  • Repeat Dose Neurotoxicity Study - Rat Conduct a repeat dose study in rats to determine the neurotoxicity of your compound.
  • Respiratory Toxicology Assess difficulty breathing, altered respiration, blood gas changes and blood pH issues due to adverse reactions.
  • Safety Pharmacology Assess the impact of a therapeutic for human use on vital organ systems before first-in-man drug testing.
  • Safety Pharmacology Latin Square Study - Dog / Canine Conduct a safety pharmacology study with a Latin square design in dogs/canines.
  • Seizure Liability Study - Rat Conduct a study to determine the seizure risk of your compound in rats.
  • Target Safety Assessment Understand the role of your drug target and assess risks in normal physiology.

Specialty Dosing Routes

  • Chronic Inhalation Carcinogenicity Study - Rat Conduct a repeat inhalation dose, chronic carcinogenicity study in rats to determine the tendency of your compound to produce tumors.
  • Chronic Intranasal Carcinogenicity Study - Rats Conduct a repeat dose intranasal, chronic carcinogenicity study in rats to determine the tendency of your compound to produce tumors.
  • Chronic Intravenous Infusion Carcinogenicity Study - Rat Conduct a repeat intravenous infusion dose, chronic carcinogenicity study in rats to determine the tendency of your compound to produce tumors.
  • Dermal Toxicology Assess toxicity in rodent dermal testing models.
  • Inhalation Toxicology Measure toxicity by daily clinical observation, body weight, clinical chemistry, hematology, and terminal necropsy and pathology.
  • Intracameral Implant Toxicity and/or Toxicokinetic Study - Dog / Canine Conduct an intracameral implant toxicity study in dogs/canines to determine the toxicity and toxicokinetic behavior of your compound.
Show all 28 in Specialty Dosing Routes 22 more
  • Intrathecal/Intraspinal Toxicology Conduct a study to determine the toxicity and toxicokinetic behavior of your compound when delivered via the intrathecal space.
  • Intravitreal Toxicity and/or Toxicokinetic Study - Dog / Canine Conduct an intravitreal ocular toxicity study in dogs/canines to determine the toxicity and toxicokinetic behavior of your compound.
  • Lethal Dose (LD), 50% Toxicity Test Measure acute toxicity by identifying the amount of pure toxin required to kill half of the experimental subjects.
  • Ophthalmologic Toxicology Measure toxicity by microscopy, vitrectomy, tonometry, electroretionography and corneal colorimetry.
  • Repeat Dose Inhalation Study - Rat Conduct a repeat dose inhalation study in rats to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Intranasal Study - Dog / Canine Conduct a repeat dose intranasal study in dogs/canines to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Intranasal Study - Mouse Conduct a repeat dose intranasal study in mice to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Intranasal Study - Rat Conduct a repeat dose intranasal study in rats to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Intravenous Infusion Study - Dog / Canine Conduct a repeat dose intravenous infusion study in dogs/canines to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Intravenous Infusion Study - Rats Conduct a repeat dose intravenous infusion study in rats to determine the toxicity and toxicokinetic behavior of your compound.
  • Single Dose Acute Inhalation Study - Rat Conduct a single dose inhalation study in rats to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Intranasal Study - Dog / Canine Conduct a single dose intranasal study in dogs/canines to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Intranasal Study - Mouse Conduct a single dose intranasal study in mice to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Intranasal Study - Rat Conduct a single dose intranasal study in rats to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Intravenous Infusion Study - Dog / Canine Conduct a single dose intravenous infusion study in dogs/canines to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Intravenous Infusion Study - Rats Conduct a single dose intravenous infusion study in rats to determine the toxicokinetic behavior of your compound.
  • Topical Dermal Toxicity and/or Toxicokinetic Study - Dog / Canine Conduct a dermal study to determine the toxicity and/or toxicokinetic behavior of your compound when applied topically to dogs/canines.
  • Topical Dermal Toxicity and/or Toxicokinetic Study - Mouse Conduct a dermal study to determine the toxicity and/or toxicokinetic behavior of your compound when applied topically to mice.
  • Topical Dermal Toxicity and/or Toxicokinetic Study - Rat Conduct a dermal study to determine the toxicity and/or toxicokinetic behavior of your compound when applied topically to rats.
  • Topical Ocular Toxicity and/or Toxicokinetic Study - Dog / Canine Conduct a topical ocular toxicity study in dogs/canines to determine the toxicity and toxicokinetic behavior of your compound.
  • Topical Ocular Toxicity and/or Toxicokinetic Study - Mouse Conduct a topical ocular toxicity study in mice to determine the toxicity and toxicokinetic behavior of your compound.
  • Topical Ocular Toxicity and/or Toxicokinetic Study - Rat Conduct a topical ocular toxicity study in rats to determine the toxicity and toxicokinetic behavior of your compound.

Target Animal and Human Food Safety

  • Tolerance Studies Conduct tolerance studies on target animals of veterinary products.
  • Toxicokinetic Analysis Determine the drug concentration at which off-target or toxic effects occur.

Testing Services

  • Elevated Temperature Stability Determine the stability of a product at elevated temperature.
  • Freeze-Thaw Testing Use freeze-thaw cycling to measure the long-term durability of cosumer products.
  • In Vitro Toxicology Testing Non-animal testing employing US and international methodologies for determining irritation and other undesirable potentials.
  • Membrane Permeability (PAMPA) Parallel Artificial Membrane Permeability Assay (PAMPA) - Measure passive diffusion of drugs by the parallel artificial membrane permeation assay.
  • OECD 439: Skin Irritation Test (SIT) Reconstructed Human Epidermis Test (RhE) Method - An in vitro testing method designed to identify chemicals and/or mixtures capable of inducing moderate skin irritation.

Other services

  • New Request  

Service areas:

Biology Pharmacology

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • China Daxing, Linjiang New District 2 sites
  • United States Waltham 2 sites

Source: Scientist.com supplier network (site locations)

About this supplier

In the supplier's own words, as listed in the Scientist.com network.

Biocytogen develops novel cytokine reporter and custom gene-targeted mouse models.

Professional associations
MassBio
Website
www.biocytogen.com

Source: Scientist.com supplier network, written by the supplier

Get the Biocytogen report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with Biocytogen on Scientist.com

For prices, more details, or to contact Biocytogen, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.